Stay updated on Roxadustat vs Darbepoetin in CKD Anemia Clinical Trial
Sign up to get notified when there's something new on the Roxadustat vs Darbepoetin in CKD Anemia Clinical Trial page.

Latest updates to the Roxadustat vs Darbepoetin in CKD Anemia Clinical Trial page
- Check5 days agoChange DetectedThe site’s displayed revision changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check12 days agoChange DetectedThe record now presents details of the completed Phase 3 trial comparing roxadustat with darbepoetin alfa for anemia in nondialysis chronic kidney disease, including its methods, eligibility criteria, and measured outcomes. It also provides study history, publications, data-sharing information, and study documents.SummaryDifference100%

- Check19 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedAn NIH transition notice banner now appears above the ClinicalTrials.gov navigation, and the site revision changed from v3.7.1 to v3.7.2. The page continues to show a 403 error instead of the study record.SummaryDifference1%

- Check40 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study content and making the NCT02021318 record inaccessible on the site.SummaryDifference19%

Stay in the know with updates to Roxadustat vs Darbepoetin in CKD Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat vs Darbepoetin in CKD Anemia Clinical Trial page.